Ftse Mib
37.722,63
-3,45%
DAX
22.326,81
-3,51%
S&P 500
5.776,76
-1,25%
NASDAQ
18.177,13
-0,94%
Bitcoin
84.127,71
-2,28%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada NEO Abbvie CDR (ABBV) Abbvie CDR (ABBV) Notizie

Abbvie CDR

ABBV
31,00
0,53 (1,74%)
18:18:03 - Dati in Tempo Reale
Borsa: NEO
Tipo: Ricevuta di Deposito
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
04/3/202514:00PRNCASKYRIZI® (risankizumab) Now Available for Moderately to..
03/3/202522:28EDGAR2Form 144 - Report of proposed sale of securities
03/3/202507:11PRNUSAbbVie and Gubra Announce License Agreement to Develop an..
28/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202522:12EDGAR2Form 144 - Report of proposed sale of securities
28/2/202508:00PRNUSAbbVie Receives Positive CHMP Opinion for Upadacitinib..
26/2/202523:47EDGAR2Form 144 - Report of proposed sale of securities
26/2/202523:04EDGAR2Form 8-K - Current report
26/2/202522:04EDGAR2Form 144 - Report of proposed sale of securities
26/2/202514:00PRNUSAbbVie to Present at the TD Cowen's 45th Annual Health Care..
24/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202523:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/2/202522:10EDGAR2Form 144 - Report of proposed sale of securities
19/2/202515:22EDGAR2Form 8-K - Current report
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:15EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
18/2/202514:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202522:31EDGAR2Form S-3ASR - Automatic shelf registration statement of..
14/2/202513:40PRNUSAbbVie Appoints CEO Robert A. Michael as Chairman of the..
14/2/202513:30EDGAR2Form 8-K - Current report
13/2/202517:57PRNUSAbbVie Declares Quarterly Dividend
12/2/202514:30PRNUSAllergan Aesthetics To Launch Three New State-of-the-Art..
12/2/202513:33GLOBEAbbVie and Xilio Therapeutics Announce Collaboration and..
12/2/202513:30PRNUSAbbVie and Xilio Therapeutics Announce Collaboration and..
07/2/202519:27PRNUSU.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for..
06/2/202514:05PRNUSAllergan Aesthetics Invites Consumers to Join the Faces of..
05/2/202522:15EDGAR2Form 8-K - Current report
05/2/202515:00PRNUSAllergan Aesthetics, the American Society of Plastic..
31/1/202513:42EDGAR2Form 8-K - Current report
31/1/202513:36PRNUSAbbVie Reports Full-Year and Fourth-Quarter 2024 Financial..
29/1/202510:00PRNUSAllergan Aesthetics launches new AA Signature Program at..
24/1/202510:00PRNUSAllergan Aesthetics unveils new AA Signature Program and..
23/1/202515:16PRNUSAbbVie Completes Acquisition of Nimble Therapeutics
23/1/202515:00PRNUSAbbVie and Neomorph Announce Collaboration to Develop..
13/1/202515:00PRNUSAbbVie and Simcere Zaiming Announce Partnership to Develop a..
13/1/202514:31PRNUSAbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314..
10/1/202514:31EDGAR2Form 8-K - Current report
09/1/202514:00PRNUSAbbVie to Present at the 43rd Annual J.P. Morgan Healthcare..
07/1/202514:00PRNUSCoolMonth is Back With Deals on CoolSculpting® Elite by..
06/1/202522:02EDGAR2Form 8-K - Current report
03/1/202514:00PRNUSAbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings..
19/12/202414:00PRNCAAbbVie's atogepant and onabotulinumtoxinA receive strong..
Apertura: 31,00 Min: 31,00 Max: 31,00
Chiusura: 30,47

La tua Cronologia

NEO
ABBV
Abbvie CDR
BIT
UC86DK
Unicredit Bank
BIT
UC7WJE
Unicredit Bank
BIT
UC5T0X
Unicredit Bank
BIT
UC3JRL
Unicredit Bank
BIT
UI485X
UniCredit
BIT
UC69E4
Unicredit Bank
BIT
UB8J4D
Unicredit Bank
BIT
UC1TJU
Unicredit Bank
BIT
UI809C
Unicredit Bank
BIT
IBTM
Exchange Traded
LSE
EXPN
Experian
BIT
UIJ154
Unicredit Bank
BIT
I10199
XS2858865384 20280911 23...
BIT
3LPO
Graniteshares 3x Long Sp...
BIT
IEAA
Exchange Traded
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci